Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1



Status:Completed
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 99
Updated:1/13/2017
Start Date:May 2001
End Date:August 2004

Use our guide to learn which trials are right for you!

Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse

The purpose of this study is to evaluate the therapeutic usefulness of incorporating
Motivational Enhancement Treatment into the standard drug abuse treatment entry process of
Community Treatment Programs on improving treatment engagement, retention, and outcome.

Participants seeking treatment at the participating CTPs will be randomly assigned to either
"standard" or "MET/MI" treatment, with a 1- and 3-month follow-up. Primary outcome measures
will include (1) treatment retention (e.g., number of sessions/weeks completed, the rate of
patients completing 3 or more subsequent sessions, and (2) substance use (e.g., urinalyses,
days of opioid, cocaine, marijuana, alcohol use, rates of abstinence). Secondary outcomes
will include motivation, psychosocial functioning, HIV risk behaviors, treatment
utilization, and patient satisfaction. Process assessments will include measures of the
working alliance as well as therapist adherence/competence ratings which will evaluate how
effectively MET/MI was implemented. Participating CTPs will implement one of two independent
protocols, depending on which is the best suited or feasible for the intake procedures at
their clinic. Thus, following an invitation to participate, explanation of the study, and
provision of informed consent, patients would complete a brief assessment battery followed
by either: 1) Random assignment to 3 individual sessions of standard treatment (treatment as
usual) at the program versus 3 individual sessions of MET. or 2) Random assignment to 1
individual standard assessment/evaluation session.

Inclusion Criteria:

Individuals will be eligible for the protocol who:

- Are seeking outpatient treatment for any substance use disorder

- Are willing to participate in the protocol (e.g., to be randomized to treatment, be
contacted for follow-up assessment, to have their sessions audiotaped)

- Are able to understand and provide written informed consent

Exclusion Criteria:

Individuals will be excluded who:

- Are not sufficiently medically or psychiatrically stable to participate in outpatient
treatment

- Are seeking detoxification only, methadone maintenance treatment or residential
inpatient treatment
We found this trial at
6
sites
Philadelphia, Pennsylvania 19102
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Norwalk, Connecticut 06852
?
mi
from
Norwalk, CT
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19123
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
San Francisco, California 94117
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Stamford, Connecticut 06901
?
mi
from
Stamford, CT
Click here to add this to my saved trials
Tarzana, California 91356
?
mi
from
Tarzana, CA
Click here to add this to my saved trials